Latest filing published 14 Dec 2007 for IMMUNE PHARMACEUTICALS INC, €7,288.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Dileep Bhagwat: trading record in brief
Dileep Bhagwat is a declared insider of Immune Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Between 23 August 2007 and 12 December 2007, the trades on record add up to 5 filings.
No open-market sale appears; the market trades are 5 purchases worth €13k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
In size, the median ticket on the buying side is €1,756.
On 14 December 2007 came the latest disclosure, an open-market purchase for €7,288 in Immune Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Dileep Bhagwat
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,500 shares@ US$1.43Common Stock, par value $0.0001SEC:0000909518-07-001072:0Canonical exit: 11 Mar 2008 (T+90)
- 2,500 shares@ US$1.42Common Stock, par value $0.0001SEC:0000909518-07-001072:1Canonical exit: 11 Mar 2008 (T+90)
- 1,500 shares@ US$1.60Common Stock, par value $0.0001SEC:0000909518-07-000783:0Canonical exit: 22 Nov 2007 (T+90)
- 400 shares@ US$1.60Common Stock, par value $0.0001SEC:0000909518-07-000782:0Canonical exit: 21 Nov 2007 (T+90)
- 600 shares@ US$1.62Common Stock, par value $0.0001SEC:0000909518-07-000782:1Canonical exit: 21 Nov 2007 (T+90)
5 of 5 declarations